Skip to main content
Damartex logo

Damartex — Investor Relations & Filings

Ticker · ALDAR ISIN · FR0000185423 LEI · 9695003JO5WBTYFJQW28 PA Wholesale and retail trade
Open in API
Filings indexed 413 across all filing types
Latest filing 2024-12-17 Share Issue/Capital Cha…
Country FR France
Listing PA ALDAR

About Damartex

https://damartex.com/en/

Damartex is a European retail group specializing in the 'silver economy,' catering to consumers aged 55 and over. The company operates a portfolio of specialized brands across three main divisions: Fashion, Home & Lifestyle, and Healthcare. The Fashion division offers clothing and accessories adapted for seniors through brands like Damart and Afibel. The Home & Lifestyle division provides products for home living and decoration. The Healthcare division delivers home health services, including specialized care such as infusion and nutrition support. The group's mission is to support the well-being of seniors by providing innovative products and services tailored to their specific needs and expectations.

Recent filings

Filing Released Lang Actions
Damartex réaffirme son éligibilité au PEA-PME
Share Issue/Capital Change Classification · 1% confidence The document is a very short press release (1441 characters) from Damartex reaffirming its eligibility for the PEA-PME investment scheme, which relates to capital market regulations and company structure eligibility. It is not a full financial report (10-K, IR), an earnings release (ER), a dividend notice (DIV), or a management change announcement (MANG). Since it is a specific regulatory/market status announcement that doesn't fit perfectly into the primary financial reporting codes, and it is not a general regulatory filing fallback (RNS), I must check the provided definitions. The content relates to the company's structure and eligibility for specific investment vehicles, which touches upon capital structure and regulatory compliance. Given the options, this type of announcement, which is a specific update on market/regulatory status (PEA-PME eligibility), is best categorized as a general Regulatory Filing (RNS) as it doesn't align with the more specific financial or corporate action codes like CAP (Financing Update) or SHA (Share Issue). However, since it is a specific announcement about market eligibility, it is often treated as a general regulatory update. I will classify it as RNS as the most appropriate fallback for a specific, non-standard regulatory status update.
2024-12-17 French
DAMARTEX / Droits de vote bruts et réels au 30 novembre 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled "INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL SOCIAL" (Monthly Information Relating to the Total Number of Voting Rights and Shares Comprising the Share Capital). It explicitly references Article 223-16 of the AMF (Autorité des Marchés Financiers) general regulation and provides a monthly update (as of November 30, 2024) on the total number of shares and voting rights. This type of regular disclosure regarding the capital structure and voting rights is a specific regulatory requirement, often falling under general regulatory announcements or specific capital change notifications. Given the options, it is a notification about the composition of the share capital and voting rights, which is a form of regulatory disclosure. It is not a full report (10-K, IR), an earnings release (ER), or a dividend notice (DIV). It most closely aligns with a specific regulatory filing or a notification related to share capital structure. Since it details the total number of shares and voting rights, it is a specific type of capital structure update. However, none of the codes perfectly match 'Monthly Voting Rights Disclosure'. Comparing the definitions, 'SHA' (Share Issue/Capital Change) is related, but this is a periodic disclosure of the *current* state, not necessarily an *announcement* of a change. 'RNS' (Regulatory Filings) is the best general fit for mandatory, periodic regulatory disclosures that don't fit elsewhere. Given the nature of the data (total shares and voting rights), it is a mandatory regulatory filing. Revisiting the options: 'SHA' relates to changes (issue/split). This is a status report. 'RNS' is the fallback for miscellaneous regulatory filings. I will classify this as a specific regulatory filing that reports on the capital structure, which is best captured by RNS as a general regulatory disclosure, although it is highly specific. If a more specific code existed for 'Voting Rights Disclosure', that would be chosen. Since it is a mandatory disclosure to the regulator (AMF), RNS is appropriate.
2024-12-12 French
Damartex / Descriptif du programme de rachat d'actions
Transaction in Own Shares Classification · 1% confidence The document is titled "Descriptif du programme de rachat d'actions" (Description of the share repurchase program). It details the purpose, maximum price, maximum amount, duration (18 months), and objectives (market liquidity, covering stock option plans) for the company buying back its own shares. This directly corresponds to the definition of 'Transaction in Own Shares' (POS), which covers share repurchase programs. Although it mentions an upcoming AGM authorization, the core content is the description of the buyback plan itself, not the AGM materials or the final voting results.
2024-11-13 French
DAMARTEX / Droits de vote bruts et réels 31 octobre 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled "INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL SOCIAL" (Monthly Information Relative to the Total Number of Voting Rights and Shares Comprising the Share Capital) and references Article 223-16 of the AMF (Autorité des Marchés Financiers) general regulation. It explicitly details the total number of shares and voting rights as of a specific date (October 31, 2024). This content directly relates to the structure of the company's capital and voting rights, which aligns best with the definition of a filing related to capital structure changes or significant shareholding notifications, although it is a specific regulatory disclosure. Reviewing the definitions: - 'SHA' (Share Issue/Capital Change) covers capital structure changes. - 'MRQ' (Major Shareholding Notification) covers changes in significant share ownership levels. Since this is a mandatory monthly disclosure of the total capital and voting rights, it is a fundamental disclosure about the share capital base. While it is not a 'Director's Dealing' (DIRS) or a 'Major Shareholding Notification' (MRQ) which usually reports *changes* by specific entities crossing thresholds, it is a direct report on the total capital structure. In many regulatory contexts, this type of periodic capital structure update is often grouped with share/capital change notifications. Given the options, 'SHA' (Share Issue/Capital Change) is the most appropriate fit for a formal report detailing the total number of shares and voting rights, as it pertains directly to the capital base. However, if we strictly interpret the definitions, this is a periodic disclosure of capital structure information. It is not a general regulatory filing (RNS) because it is highly specific. It is not a 'Major Shareholding Notification' (MRQ) as it reports the total, not changes by major holders. It is a report on the capital base, making 'SHA' the closest fit among the specific codes provided for capital structure reporting.
2024-11-08 French
Damartex / Chiffre d’affaires du 1er trimestre de l’exercice 2024/2025
Earnings Release Classification · 1% confidence The document explicitly details the 'Chiffre d'affaires du 1er trimestre de l'exercice 2024/2025' (First Quarter Revenue for the 2024/2025 fiscal year), providing consolidated figures, segment breakdowns (Fashion, Home & Lifestyle, Healthcare), and commentary on performance. This content structure—a periodic financial summary focusing on revenue and operational highlights for a period shorter than a full year—is characteristic of an Interim/Quarterly Report. Although it is brief, it contains the core financial data rather than just announcing the release of a report. Therefore, it aligns best with the Interim / Quarterly Report (IR) definition, rather than an Earnings Release (ER) which is usually just the highlights, or a Report Publication Announcement (RPA) which only announces the publication. Q1 2025
2024-10-17 French
DAMARTEX / Droits de vote bruts et réels au 30 septembre 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled "INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL SOCIAL" (Monthly Information Relating to the Total Number of Voting Rights and Shares Comprising the Share Capital). It explicitly references Article 223-16 of the AMF (Autorité des Marchés Financiers) general regulation and provides a monthly update (as of September 30, 2024) on the total number of shares and voting rights. This type of mandatory periodic disclosure regarding the capital structure and voting rights does not fit neatly into the primary categories like 10-K, ER, or IR. It is a specific regulatory disclosure concerning share capital and voting rights, which is best categorized under the general 'Regulatory Filings' (RNS) as a miscellaneous, mandatory filing that doesn't match the more specific definitions (like DIRS for director dealing or SHA for share issuance). Given the options, RNS is the most appropriate fallback for this specific, non-standard regulatory notice.
2024-10-10 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.